This company has been acquired
La Jolla Pharmaceutical Balance Sheet Health
Financial Health criteria checks 0/6
La Jolla Pharmaceutical has a total shareholder equity of $-69.5M and total debt of $124.5M, which brings its debt-to-equity ratio to -179.3%. Its total assets and total liabilities are $99.4M and $168.8M respectively.
Key information
-179.3%
Debt to equity ratio
US$124.54m
Debt
| Interest coverage ratio | n/a |
| Cash | US$48.66m |
| Equity | -US$69.47m |
| Total liabilities | US$168.83m |
| Total assets | US$99.37m |
Recent financial health updates
No updates
Recent updates
Innoviva to acquire La Jolla Pharma for $149M including debt
Jul 11We Think La Jolla Pharmaceutical's (NASDAQ:LJPC) Robust Earnings Are Conservative
Nov 11
Our Take On La Jolla Pharmaceutical Company
Jul 02La Jolla Pharmaceutical EPS misses by $0.14, beats on revenue
May 07La Jolla Pharmaceutical's (NASDAQ:LJPC) Shareholders Are Down 82% On Their Shares
Mar 11Market Sentiment Around Loss-Making La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Feb 11Industry Analysts Just Upgraded Their La Jolla Pharmaceutical Company (NASDAQ:LJPC) Revenue Forecasts By 18%
Jan 16La Jolla Pharmaceutical rallies on exclusive licensing agreement with PAION
Jan 12Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?
Jan 05Could The La Jolla Pharmaceutical Company (NASDAQ:LJPC) Ownership Structure Tell Us Something Useful?
Dec 09La Jolla Pharmaceutical EPS beats by $0.11, beats on revenue
Nov 09Financial Position Analysis
Short Term Liabilities: LJPC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: LJPC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: LJPC has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: LJPC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: LJPC's debt is not well covered by operating cash flow (10.5%).
Interest Coverage: Insufficient data to determine if LJPC's interest payments on its debt are well covered by EBIT.